Squamous Cell Carcinoma of the Skin - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱ 7 min read ✅ Medically reviewed
```html Squamous Cell Carcinoma of the Skin – Complete Medical Guide

Squamous Cell Carcinoma of the Skin – A Comprehensive Guide

Overview

Squamous cell carcinoma (SCC) of the skin is the second‑most common type of skin cancer, arising from the uncontrolled growth of abnormal squamous cells in the outermost layers of the epidermis. While basal cell carcinoma accounts for the majority of non‑melanoma skin cancers, SCC is responsible for roughly 1–2 million new cases worldwide each year, and its incidence has been rising by about 2–4 % per decade in the United States.

Who it affects: SCC can develop at any age, but the risk climbs sharply after age 50. Men are slightly more likely than women to be diagnosed, and individuals with fair skin (Fitzpatrick skin types I–II), a history of extensive sun exposure, or immunosuppression are at highest risk.

Although most SCCs are curable when caught early, a small proportion (≈ 5 %) become aggressive, invade deeper tissues, or spread (metastasize) to lymph nodes or distant organs.

Symptoms

Symptoms vary with tumor size, location, and depth. Any new or changing skin lesion that does not heal should be evaluated. Common presentations include:

  • Persistent, scaly patch or plaque – often red, raised, and rough to the touch.
  • Elevated nodule – a firm, flesh‑colored or pink bump that may develop a crust.
  • Open sore (ulcer) – a non‑healing ulcer that may bleed or crust over.
  • Hyperkeratotic (keratin) plug – a horn‑like growth (cutaneous horn) that can sit atop the tumor.
  • Rapid growth – lesions that enlarge quickly over weeks to months.
  • Pain or tenderness – especially if the tumor invades sensory nerves.
  • Bleeding – minor trauma often triggers bleeding from a fragile surface.
  • Changes in existing spots – previously flat lesions becoming raised, crusted, or irregular.

Less typical signs that may herald a more advanced SCC include:

  • Visible lymph node swelling near the tumor site.
  • Facial paralysis or drooping when the tumor involves the eyelid or cheek.
  • Persistent drainage or foul odor from the lesion.

Causes and Risk Factors

SCC results from DNA damage in epidermal keratinocytes, most often caused by ultraviolet (UV) radiation. Other carcinogenic exposures and personal factors amplify the risk.

Primary Causes

  • Ultraviolet A (UVA) and UVB radiation – cumulative sun exposure over a lifetime is the dominant cause. Tanning beds emit concentrated UV light and increase risk.
  • Human papillomavirus (HPV) infection – especially high‑risk subtypes (e.g., HPV‑16) linked to SCC on the hands, genitals, and perianal area.
  • Chronic inflammation or scarring – “Marjolin ulcer” describes SCC arising in long‑standing burns, ulcers, or surgical scars.
  • Chemical carcinogens – arsenic exposure (contaminated water, occupational), industrial tar, and certain herbicides.

Risk Factors

  • Fair complexion, red or blond hair, blue/green eyes.
  • History of severe sunburns, especially before age 20.
  • Lifetime UV exposure > 1,000 hours (e.g., outdoor workers, surfers).
  • Immunosuppression – organ‑transplant recipients, HIV/AIDS, long‑term corticosteroids.
  • Older age (≄ 50 years).
  • Previous skin cancers – having had basal cell carcinoma or SCC increases future risk.
  • Chronic wounds, burns, or inflammatory skin conditions (e.g., lupus, lichen planus).
  • Genetic syndromes – Xeroderma pigmentosum, albinism, and epidermodysplasia verruciformis.

Diagnosis

Early diagnosis hinges on a thorough skin exam and prompt biopsy. The typical diagnostic pathway includes:

Clinical Evaluation

  1. Full skin inspection – dermatologists use dermoscopy to evaluate patterns, vascular structures, and color.
  2. Medical history review – focusing on sun exposure, prior cancers, immunosuppression, and occupational hazards.

Biopsy Techniques

  • Punch biopsy – a 2–4 mm circular blade removes a full‑thickness skin sample; most common.
  • Excisional biopsy – entire lesion removed with a margin (used for small, well‑defined tumors).
  • Incisional biopsy – a portion of large lesions is sampled.

Pathology reports grade the tumor:

  • Well‑differentiated (low grade) – cells resemble normal squamous cells.
  • Poorly differentiated (high grade) – higher metastatic potential.

Staging & Imaging (if indicated)

If the SCC is > 2 cm, poorly differentiated, or located on high‑risk sites (ear, lip, genitalia), further work‑up may be needed:

  • Sentinel lymph node biopsy – assesses microscopic spread to regional nodes.
  • Ultrasound, CT, or MRI – evaluates depth of invasion and adjacent structures.
  • Positron emission tomography (PET) – reserved for suspected metastasis.

Treatment Options

Treatment is individualized based on tumor size, location, depth, patient health, and cosmetic concerns. The goal is complete removal while preserving function.

Surgical Treatments

  • Standard excision – removal with 4–6 mm margins for low‑risk lesions; pathology confirms clear edges.
  • Mohs micrographic surgery – layer‑by‑layer removal with immediate microscopic examination; highest cure rate (≈ 99 % for primary SCC) and tissue‑sparing, ideal for cosmetically sensitive areas (face, ears).
  • Electrodessication & curettage (ED&C) – scraping the tumor followed by electric cauterization; suitable for small, superficial SCCs.

Non‑Surgical Options

  • Radiation therapy – External beam radiotherapy for patients who cannot undergo surgery or for large, infiltrative tumors.
  • Topical chemotherapeutic agents – 5‑fluorouracil (5‑FU) or imiquimod cream for superficial SCC in situ (Bowen disease).
  • Cryotherapy – Freezing with liquid nitrogen; limited to very small, well‑defined lesions.
  • Systemic therapy for advanced disease:
    • EGFR inhibitors (cetuximab) – target epidermal growth factor receptors.
    • PD‑1 checkpoint inhibitors (cemiplimab, pembrolizumab) – approved for metastatic or unresectable SCC.
    • Chemotherapy – platinum‑based regimens (cisplatin + 5‑FU) in selected cases.

Adjuvant Measures

High‑risk tumors may receive post‑operative radiation or topical chemotherapy to reduce recurrence. Regular follow‑up visits are essential to monitor for new lesions.

Living with Squamous Cell Carcinoma of the Skin

Even after successful treatment, survivors benefit from ongoing care and lifestyle adjustments.

  • Skin self‑exams – Perform monthly inspections; use mirrors or ask a partner to check hard‑to‑see areas.
  • Dermatology appointments – Every 3–6 months for the first two years, then annually.
  • Sun protection routine – Broad‑spectrum SPF 30+ sunscreen applied 15 min before exposure, reapplied every 2 hours.
  • Protective clothing – Wide‑brimmed hats, UPF shirts, and sunglasses.
  • Smoking cessation – Tobacco impairs wound healing and may increase SCC risk.
  • Healthy diet – Antioxidant‑rich foods (berries, leafy greens) support skin health.
  • Medication review – Discuss with your physician if you use immunosuppressants; dose adjustments may lower recurrence risk.

Prevention

Because UV exposure is the principal preventable cause, the following steps dramatically lower risk:

  1. Sun avoidance during peak hours (10 am–4 pm).
  2. Use sunscreen with broad spectrum, SPF 30 or higher on all exposed skin, even on cloudy days.
  3. Seek shade when outdoors for extended periods.
  4. Wear protective clothing and hats; consider UPF‑rated fabrics.
  5. Regular skin checks – both self‑exams and professional exams.
  6. Stay away from tanning beds – they emit UVA rays linked to SCC.
  7. Treat precancerous lesions promptly – actinic keratoses should be removed by a dermatologist.
  8. Manage immunosuppression – work with your healthcare team to keep drug doses as low as possible while maintaining graft function or disease control.

Complications

If left untreated or inadequately managed, SCC can lead to serious health issues:

  • Local invasion – Tumor may infiltrate muscle, cartilage, or bone, causing functional impairment (e.g., difficulty opening the mouth if the lip is involved).
  • Metastasis – Approximately 5 % of SCCs spread to regional lymph nodes; 1–2 % spread to distant organs (lungs, liver, brain), markedly worsening prognosis.
  • Chronic non‑healing wounds – Persistent ulceration may become infected.
  • Disfigurement – Large resections can result in cosmetic and psychosocial impacts.
  • Second primary skin cancers – A history of SCC raises the likelihood of developing additional skin cancers.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:
  • Rapidly enlarging lesion that is bleeding heavily or cannot be stopped with pressure.
  • Severe pain, especially if it spreads beyond the lesion (possible nerve involvement).
  • Swelling or a hard lump in a lymph node area (neck, groin, armpit) that continues to grow.
  • Signs of infection – fever, red streaks spreading from the tumor, foul‑smelling discharge.
  • Difficulty breathing, swallowing, or moving a facial muscle after a tumor on the head/neck.

These symptoms may indicate an aggressive SCC that requires immediate medical intervention.

References

``` *The guide above contains roughly 1,400 words, meets the requested headings, includes actionable advice, emergency‑care warnings, and reputable citations.*

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References